查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球脊柱融合设备市场 - 2023-2030年
市场调查报告书
商品编码
1290359

全球脊柱融合设备市场 - 2023-2030年

Global Spinal Fusion Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球脊柱融合器市场规模在2022年达到76.664亿美元，预计到2030年将见证有利可图的增长，达到108.274亿美元。在预测期内（2023-2030年），全球脊柱融合设备市场的年复合增长率为4.5%。

脊柱融合术通常用于治疗各种脊柱疾病，包括退行性椎间盘疾病、椎管狭窄、脊柱骨折、脊柱侧弯和脊柱不稳定。该手术涉及使用植入物或骨移植物连接或融合两个或多个相邻的椎体，在它们之间建立一个坚实的骨桥。

脊柱融合器市场受到以下因素的驱动：老龄化人口和肥胖人口的增加，意识和病人教育的增长，脊柱疾病的发病率增加，技术的进步，以及对微创手术的日益青睐。

市场动态

脊柱疾病的发病率不断提高

脊柱疾病患病率的增加是在预测期内推动脊柱融合器械市场份额的主要因素。人口老龄化、久坐不动的生活方式和肥胖症是导致脊柱融合器产生机会的主要因素。

随着全球人口的不断老龄化，脊柱疾病的发病率预计将上升。与年龄有关的退行性疾病，如退行性椎间盘疾病和椎管狭窄，随着年龄的增长而变得更加普遍。脊柱结构的退化，包括椎间盘、关节和韧带，会导致疼痛、丧失活动能力和脊柱不稳定。

肥胖症发病率的上升与脊柱疾病风险的增加密切相关。过重的体重会给脊柱带来额外的压力，导致脊柱结构的加速磨损，并增加患退行性椎间盘疾病和脊柱骨关节炎等疾病的可能性。

高昂的治疗费用

高昂的治疗费用是脊柱融合领域的一个重要制约因素，会影响患者、医疗系统和脊柱融合器械的采用。脊柱融合手术是一个复杂的过程，涉及到专业医疗人员团队、先进的手术设备和术后护理。手术的费用包括与手术室、麻醉、外科医生费用、住院和康复有关的费用。

这些费用可能因手术的复杂性、医疗机构的位置和病人的具体需求等因素而有所不同。新的脊柱融合设备和技术的开发涉及大量的研究和开发工作，这可能导致更高的治疗费用。这些成本通常会转嫁到病人和医疗系统身上。

COVID-19影响分析

COVID-19大流行病对脊柱融合器械市场产生了重大影响。参与脊柱融合手术的脊柱外科医生和医护人员被重新安排到与COVID-19相关的活动中，包括病人护理、研究和疫苗接种工作。这种优先事项和资源的转移可能导致脊柱融合手术的减少和新设备或技术的采用暂时放缓。

由于担心在医疗机构中感染病毒，或认为住院和术后护理有风险，病人在大流行期间对接受选择性手术犹豫不决。这种不愿意接受脊柱融合手术的态度可能进一步导致了对脊柱融合器械需求的下降。

随着疫苗接种工作的进展和医疗系统从大流行病的影响中恢复过来，预计会有积压的脊柱融合手术被推迟。这种被压抑的需求，再加上选择性手术的恢复，可能会导致脊柱融合器械的需求在大流行后的时期出现反弹。

俄罗斯-乌克兰冲突分析

俄乌冲突极大地影响了脊柱融合器的市场。冲突会产生重大的经济后果，包括货币波动、通货膨胀和购买力下降。这些经济因素会影响医疗预算，有可能导致包括脊柱融合器在内的医疗设备支出减少。

冲突会扰乱医疗设备的供应链，包括脊柱融合设备。这两个国家在医疗保健产品的制造和分销方面都发挥着重要作用。运输路线的任何中断、边境关闭或政治紧张局势都可能导致脊柱融合器械供应的延迟或中断。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品类型抽查
  • 按手术地点分类
  • 按应用分类
  • 按终端用户分类
  • 按地区分类

第4章：动态变化

  • 影响因素
    • 驱动因素
      • 脊柱疾病的发病率越来越高
      • 对微创手术的需求不断增加
    • 限制因素
      • 治疗费用高
      • 可供选择的治疗方法
    • 机会
      • 外科技术的进步
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第七章：按产品类型

  • 椎弓根螺钉
  • 椎间盘
  • 骨移植
  • 脊柱融合刺激器
  • 其他产品

第8章：按手术位置分类

  • 颈椎融合器
  • 腰椎融合器
  • 胸椎融合器
  • 其它

第九章：按应用分类

  • 退行性椎间盘疾病
  • 脊柱滑脱症
  • 椎管狭窄症
  • 脊柱侧弯
  • 脊柱外伤
  • 肿瘤
  • 其他

第十章：按终端用户分类

  • 医院
  • 非住院手术诊所
  • 专业诊所
  • 其他

第十一章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第十二章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併和收购分析

第十三章 ：公司简介

  • Medtronic plc
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • Johnson & Johnson
  • Stryker Corporation
  • NuVasive Inc.
  • Zimmer Biomet Holdings Inc.
  • Globus Medical Inc.
  • Spinal Elements Inc.
  • Xtant Medical Holdings Inc.
  • RTI Surgical Inc.
  • ATEC spine Inc.

第十四章：附录

简介目录
Product Code: MD1636

Market Overview

The Global Spinal Fusion Devices Market size reached US$ 7,666.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 10,827.4 million by 2030. The global spinal fusion devices market is exhibiting a CAGR of 4.5% during the forecast period (2023-2030).

Spinal fusion is typically performed to treat various spinal conditions, including degenerative disc disease, spinal stenosis, spinal fractures, scoliosis, and spinal instability. The procedure involves joining or fusing two or more adjacent vertebrae using implants or bone grafts to create a solid bone bridge between them.

The spinal fusion devices market is driven by factors such as the rising aging population and obese population, growing awareness and patient education, increasing prevalence of spinal disorders, technological advancements, and growing preference for minimally invasive procedures.

Market Dynamics

Increasing Prevalence of Spinal Disorders

The increasing prevalence of spinal disorders is the major factor driving the spinal fusion devices market share during the forecast period. The aging population, sedentary lifestyle, and obesity are the major factors leading to creating a chance for spinal fusion devices.

As the global population continues to age, the prevalence of spinal disorders is expected to rise. Age-related degenerative conditions, such as degenerative disc disease and spinal stenosis, become more common with advancing age. The degeneration of spinal structures, including discs, joints, and ligaments, can lead to pain, loss of mobility, and spinal instability.

The rising prevalence of obesity is strongly linked to an increased risk of spinal disorders. Excess weight places additional stress on the spine, leading to accelerated wear and tear of spinal structures and an increased likelihood of developing conditions such as degenerative disc disease and spinal osteoarthritis.

High Treatment Costs

High treatment costs are a significant restraint in the field of spinal fusion and can impact patients, healthcare systems, and the adoption of spinal fusion devices. Spinal fusion surgery is a complex procedure that involves a team of specialized healthcare professionals, advanced surgical equipment, and postoperative care. The cost of the surgery includes expenses related to the operating room, anesthesia, surgeon fees, hospital stay, and rehabilitation.

These costs can vary depending on factors such as the complexity of the procedure, the location of the healthcare facility, and the patient's specific needs. The development of new spinal fusion devices and technologies involves significant research and development efforts, which can contribute to higher treatment costs. These costs are often passed on to patients and healthcare systems.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the spinal fusion devices market. Spinal surgeons and healthcare professionals involved in spinal fusion procedures were redirected to COVID-19-related activities, including patient care, research, and vaccination efforts. This shift in priorities and resources could have resulted in a decrease in spinal fusion surgeries and a temporary slowdown in the adoption of new devices or technologies.

Patients were hesitant to undergo elective surgeries during the pandemic due to concerns about contracting the virus in healthcare settings or the perceived risk associated with hospitalization and postoperative care. This reluctance to undergo spinal fusion procedures may have further contributed to the decline in demand for spinal fusion devices.

As vaccination efforts progress and healthcare systems recover from the pandemic's impact, there is expected to be a backlog of deferred spinal fusion surgeries. This pent-up demand, coupled with the resumption of elective surgeries, could lead to a rebound in the demand for spinal fusion devices in the post-pandemic period.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict significantly impacted the spinal fusion devices market. The conflict can have significant economic consequences, including currency fluctuations, inflation, and reduced purchasing power. These economic factors can influence healthcare budgets, potentially leading to reduced spending on medical devices, including spinal fusion devices.

The conflict can disrupt the supply chain of medical devices, including spinal fusion devices. Both countries play a significant role in the manufacturing and distribution of healthcare products. Any disruptions in transportation routes, border closures, or political tensions can lead to delays or interruptions in the availability of spinal fusion devices.

Segment Analysis

The global spinal fusion devices market is segmented based on product type, procedure location, application, end-user, and region.

Based on the Product Type, the Pedicle Screws Segment is Expected to Dominate the Market Share

Based on the product type, the pedicle screw segment is expected to dominate the market share accounting for 46.4% during the forecast period. Pedicle screws are widely used in spinal fusion surgeries to provide stability and support during the fusion process. Pedicle screws offer excellent stability by anchoring into the pedicles, which are bony protrusions on the vertebrae. This stability helps maintain proper alignment of the spine during the fusion process and promotes successful fusion.

Minimally invasive spinal fusion procedures have gained popularity due to their potential benefits, including smaller incisions, reduced muscle damage, and faster recovery. Pedicle screws are an essential component of minimally invasive approaches, enabling surgeons to achieve spinal fusion with less tissue disruption.

Geographical Analysis

North America Holds The Largest Market Share Of 38.5% Due To The Rising Prevalence Of Spinal Disorders And The Presence Of Major Players

North America holds the largest market share during the forecast period due to the rising prevalence of spinal disorders and the presence of major players. North America has a high prevalence of spinal disorders, including degenerative disc disease, herniated discs, and spinal stenosis. These conditions can cause severe pain and mobility issues, leading to the need for spinal fusion procedures. The increasing prevalence of these disorders drives the demand for spinal fusion devices in the region.

The presence of major players in this region, like Merck KGaA, Harvard Bioscience Inc. (BTX), Thermo Fisher Scientific, Inc., Bio-Rad Laboratories., and Lonza Group, are expected to boost the growth of the market over the forecast period.

Competitive Landscape

The major global players in the market include: Medtronic plc, Johnson & Johnson, Stryker Corporation, NuVasive Inc., Zimmer Biomet Holdings Inc., Globus Medical Inc., Spinal Elements Inc., Xtant Medical Holdings Inc., RTI Surgical Inc., and ATEC spine Inc.

Why Purchase the Report?

  • To visualize the global spinal fusion devices market segmentation based on product type, procedure location, application, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of spinal fusion devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global spinal fusion devices market report would provide approximately 54 tables, 46 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Procedure Location
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of spinal disorders
      • 4.1.1.2. Increasing demand for minimally invasive procedures
    • 4.1.2. Restraints
      • 4.1.2.1. High treatment costs
      • 4.1.2.2. Availability of alternative treatment options
    • 4.1.3. Opportunity
      • 4.1.3.1. Advancements in surgical techniques
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pedicle Screws*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Plates
  • 7.4. Bone grafts
  • 7.5. Spinal fusion stimulators
  • 7.6. Others

8. By Procedure Location

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 8.1.2. Market Attractiveness Index, By Procedure Location
  • 8.2. Cervical spinal fusion devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Lumbar spinal fusion devices
  • 8.4. Thoracic spinal fusion devices
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Degenerative Disk Disease*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Spondylolisthesis
  • 9.4. Spinal stenosis
  • 9.5. Scoliosis
  • 9.6. Spinal trauma
  • 9.7. Tumors
  • 9.8. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory surgical clinics
  • 10.4. Specialty clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic plc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Johnson & Johnson
  • 13.3. Stryker Corporation
  • 13.4. NuVasive Inc.
  • 13.5. Zimmer Biomet Holdings Inc.
  • 13.6. Globus Medical Inc.
  • 13.7. Spinal Elements Inc.
  • 13.8. Xtant Medical Holdings Inc.
  • 13.9. RTI Surgical Inc.
  • 13.10. ATEC spine Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us